Trends in premature avertable mortality from non-communicable diseases for 195 countries and territories, 1990–2017: a population-based study

Abstract

Background The reduction by a third of premature non-communicable disease (NCD) mortality by 2030 is the ambitious target of Sustainable Development Goal (SDG) 3.4. However, the indicator is narrowly defined, including only four major NCDs (cardiovascular diseases, cancer, diabetes, and chronic respiratory diseases) and only for people aged 30−70 years. This study focuses on premature avertable mortality from NCDs-premature deaths caused by NCDs that could be prevented through effective public policies and health interventions or amenable to high-quality health care-to assess trends at global, regional, and national levels using estimates from the Global Burden of Disease, Injuries, and Risk Factors Study (GBD) 2017. MethodsWe reviewed existing lists of NCD causes of death that are either preventable through public health policies and interventions or amenable to health care to create a list of avertable NCD causes of death, which was mapped to the GBD cause list. We estimated age-standardised years of life lost (YLL) per 100 000 population due to premature avertable mortality from NCDs, avertable NCD cause clusters, and non-avertable NCD causes by sex, location, and year and reported their 95% uncertainty intervals (UIs). We examined trends in age-standardised YLL due to avertable and nonavertable NCDs, assessed the progress of premature avertable mortality from NCDs in achieving SDG 3.4, and explored specific avertable NCD cause clusters that could make a substantial contribution to overall trends in premature mortality. Findings Globally, premature avertable mortality from NCDs for both sexes combined declined -1•3% (95%UI -1•4 to -1•2) per year, from 12 855 years (11 809 to 14 051) in 1990 to 9008 years (8329 to 9756) in 2017. However, the absolute number of avertable NCD deaths increased 49•3% (95% UI 47•3 to 52•2) from 23•1 million (22•0-24•1) deaths in 1990 to 34•5 million (33•4 to 35•6) in 2017. Premature avertable mortality from NCDs reduced in every WHO region and in most countries and territories between 1990 and 2017. Despite these reductions, only the Western Pacific and European regions and 25 countries (most of which are high-income countries) are on track to achieve SDG target 3.4. Since 2017, there has been a global slowdown in the reduction of premature avertable mortality from NCDs. In 2017, high premature avertable mortality from NCDs was clustered in low-income and middle-income countries, mainly in the South-East Asia region, Eastern Mediterranean region, and African region. Most countries with large annual reductions in such mortality between 1990 and 2017 had achieved low levels of premature avertable mortality from NCDs by 2017. Some countries, the most populous examples being Afghanistan,

Management of prepregnancy, pregnancy, and postpartum obesity from the FIGO Pregnancy and Non‐Communicable Diseases Committee: A FIGO (International Federation of Gynecology and Obstetrics) guideline

“…Obesity increases the risk of noncommunicable diseases (NCDs), such as type 2 diabetes and cardiovascular disease, which contribute to over 70% of global deaths annually 5,6 . This is especially important in LMICs where 86% of premature NCD deaths occur 7 . Increasing evidence from the developmental origins of health and disease paradigm suggests that obesity during pregnancy not only increases the mother’s risk of later NCDs but can also transfer the risk to the offspring through epigenetic mechanisms, alterations in gut microbiome, and sociocultural factors 8 .…”

The slowdown in the reduction rate of premature mortality from cardiovascular diseases puts the Americas at risk of achieving SDG 3.4: A population trend analysis of 37 countries from 1990 to 2017

“…Although CVD age‐standardized disability‐adjusted life years (DALY) rate per population has decreased remarkably from 1990 to 2015, one‐third of the 1.9 million annual CVD deaths in the region occurred in people aged less than 70 years 2,3 . Moreover, more than 80% the CVD burden could be averted since IHD, stroke, and hypertensive heart disease (HHD) can be prevented through effective population‐based interventions and policies to tackle unhealthy diets (including sodium reduction and trans‐fat elimination), tobacco use, physical inactivity, and alcohol use and are amenable to health care (eg, hypertension management, CVD secondary prevention, and treatment of acute cardiovascular events) 4,5 . The Sustainable Development Goals Agenda 2030 (SDGs) 6 and the WHO NCD Global Action Plan 2013‐2020 7 have recognized the importance of CVD by targeting a one‐third reduction in premature mortality due to NCDs by 2030 while leaving no one behind .…”

No lockdown for neurological diseases during COVID19 pandemic infection

“…Nonetheless, the healthcare system needs to continue to respond to the needs of patients affected by noncommunicable diseases [6], which are the majority of conditions. In this regard, neurological disorders contribute to 11,6% of global DALYs and 16,5% of deaths from all causes, remaining the leading group cause of DALYs and the second leading group cause of deaths in the world [7].…”